" class="no-js "lang="en-US"> Exothera - Medtech Alert
Friday, August 22, 2025
Exothera | Pharmtech Focus

Exothera

About Exothera

Exothera

Exothera is a viral vector contract manufacturing and development organization (CDMO) using standard and innovative bioproduction platforms to rapidly deliver affordable viral vector-based vaccines and cell and gene therapies. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.

Related Story

Exothera Announces Industrial Scale AAV Manufacturing Collaboration With LogicBio Therapeutics and Polyplus

June 15 2022

Exothera SA today announced a collaboration with LogicBio® Therapeutics and Polyplus-transfection® SA. for the development of […]